B. Riley Has Optimistic Outlook of Abacus Life Q2 Earnings

Abacus Life, Inc. (NASDAQ:ABL - Free Report) - Research analysts at B. Riley increased their Q2 2025 EPS estimates for shares of Abacus Life in a report issued on Thursday, May 15th. B. Riley analyst R. Binner now expects that the company will post earnings per share of $0.18 for the quarter, up from their prior estimate of $0.16. The consensus estimate for Abacus Life's current full-year earnings is $0.62 per share. B. Riley also issued estimates for Abacus Life's Q4 2025 earnings at $0.20 EPS.

ABL has been the topic of several other reports. Maxim Group started coverage on shares of Abacus Life in a research report on Tuesday, April 29th. They issued a "buy" rating and a $14.00 price target on the stock. Piper Sandler increased their price target on shares of Abacus Life from $11.50 to $12.00 and gave the company an "overweight" rating in a research report on Friday, May 9th. Six research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus price target of $14.08.

Abacus Life Price Performance

Shares of ABL stock traded down $0.15 during mid-day trading on Monday, reaching $8.76. The stock had a trading volume of 238,723 shares, compared to its average volume of 201,972. The business has a 50-day simple moving average of $7.92 and a 200 day simple moving average of $7.86. The company has a market cap of $848.43 million, a P/E ratio of -48.66 and a beta of 0.14. Abacus Life has a 12-month low of $6.34 and a 12-month high of $12.40. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.65.

Abacus Life (NASDAQ:ABL - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The company reported $0.18 earnings per share for the quarter, beating analysts' consensus estimates of $0.16 by $0.02. Abacus Life had a positive return on equity of 12.88% and a negative net margin of 11.65%. The business had revenue of $44.14 million during the quarter, compared to analysts' expectations of $39.51 million.

Hedge Funds Weigh In On Abacus Life

A number of institutional investors have recently modified their holdings of ABL. Geneos Wealth Management Inc. purchased a new position in Abacus Life during the fourth quarter worth about $110,000. State of Wyoming acquired a new position in Abacus Life during the first quarter worth approximately $105,000. Squarepoint Ops LLC acquired a new position in Abacus Life during the fourth quarter worth approximately $113,000. JPMorgan Chase & Co. increased its position in Abacus Life by 640.9% during the fourth quarter. JPMorgan Chase & Co. now owns 16,670 shares of the company's stock worth $131,000 after purchasing an additional 14,420 shares during the last quarter. Finally, LPL Financial LLC increased its position in Abacus Life by 31.0% during the fourth quarter. LPL Financial LLC now owns 23,288 shares of the company's stock worth $182,000 after purchasing an additional 5,507 shares during the last quarter.

Abacus Life Company Profile

Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.